In this issue:
Allogeneic HCT in Hodgkin lymphoma after checkpoint inhibitors
Allograft outcomes for chronic lymphocytic leukaemia
Length of stay in high-risk patients undergoing allograft
Prebiotic fibre enteral supplementation after allogeneic transplantation
Haematological malignancy and bone marrow failure syndromes
Allograft and quizartinib for AML and FLT-3-internal tandem duplications
Sinusoidal obstruction syndrome after allograft
Second allograft in relapsed B-cell acute lymphoblastic leukaemia
Please login below to download this issue (PDF)